NCT04964453 - A Study in Healthy Men to Test How BI 474121 is Tolerated | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

November 11, 2021

Study Completion Date

November 16, 2021

Conditions

Healthy

Interventions

DRUG

Placebo

Healthy subjects were given a single dose of placebo tablet(s) matched to the active treatment, subjects receiving placebo were equally distributed across dose groups. Tablet(s) were taken orally with 240 milliliter of water after an overnight fast of at least 10 hours.

DRUG

BI 474121

Healthy subjects were given a single dose of BI 474121 as a uncoated tablet(s) taken orally with 240 milliliter of water after an overnight fast of at least 10 hours.

Trial Locations (1)

130-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku